Aastrom Biosciences, Inc. reports on the results of Phase I/II clinical trials of the TRC [Tissue Repair Cells] product in patients with bone fractures
- Authors: Volkov A.V., Bersenev A.V.
- Issue: Vol 1, No 2 (2006)
- Pages: 28-28
- Section: Cell technology
- URL: https://genescells.ru/2313-1829/article/view/217697
- DOI: https://doi.org/10.23868/gc217697
Cite item
Open Access
Access granted
Full Text
About the authors
A. V. Volkov
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation
A. V. Bersenev
Email: redaktor@celltranspl.ru
Russian Federation
References
- Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities. 2005, MedMarket Diligense, LLC.
